Celltech, the biotechnology company, said that its antibody treatment for Crohn's disease-a serious bowel condition-could reach the US market up to a year earlier than expected after the regulator
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/celltech-approval-year-earlier
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/financial-times-london
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health